HPV testing: Where are we now?

Anticancer Research

Volumn 20, Issue 6 C, 2000, Pages 4673-4680

  Bovicelli, A ^a   Bristow, R E ^a   Montz, F J ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cervical cancer screening; Diagnosis; HPV testing

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; UTERINE CERVIX CANCER; WART VIRUS;

DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034495791     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Estimates of the worldwide incidence of eighteen major cancers in 1985
2. The epidemiology of cervical carcinogenesis
3. Prevalence of human papillomavirus in cervical cancer: A worldwide prospective
4. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
5. Natural history of cervicovaginal papillomavirus infection in young women
6. Absence of papillomavirus DNA in normal tissue adjacent to most cervical intraepithelial neoplasms
7. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease : Natural history up to 36 months
8. Cancer incidence and mortality, 1973- 1995
9. Death of Papanicolau smear? A tale of three reasons
10. Where is the high grade cervical neoplasia ? The importance of the minimally abnormal Papanicolau diagnosis
11. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities
12. Identifying women with cervical neoplasia using human Papillomavirus DNA testing for equivocal Papanicolau results
13. Viral testing for genital human Papillomavirus infections: Recent progress and clinical potentials
14. Prospects for automated cytology
15. Cytorich liquid-based cervical cytologic test. Screening results in a routine cytopathology service
16. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human Papillomavirus testing
17. Interim guidelines for management of abnormal cytology
18. Cervical Pap smear: New directions
19. HPV-DNA testing comes of age
20. Human Papillomavirus testing by Hybrid Capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance
21. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia
22. Comparison between methods for Human Papillomavirus DNA testing: A model for self-testing in young women
23. HPV-DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
24. Evaluating the role of HPV testing for women with equivocal Papanicolau test findings
25. Diagnostic performance of Hybrid Capture Human Papilllomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study
26. An evaluation of Human Papillomavirus testing as a part of referrral to colposcopy clinic
27. Human Papillomavirus typing in patients with Papanicolau smears showing squamous atypia
28. Human Papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: Sensitivity, specificity, and cost-effectiveness
29. Short- term fluctuations in the detection of cervical Human Papillomavirus DNA
30. Evaluation of the Hybrid Capture Human Papillomavirus deoxyribonucleic acid detection test
31. Human Papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by Polymerase chain reaction
32. Persistence of Human Papillomavirus preceding cervical carcinoma
33. A Pcr study on the coexistence of Herpes simplex virus, cytomegalovirus and Human Papillomavirus DNAs in cervical neoplasia
34. Reflex Human Papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolau smears
35. Triage of women with ASCUS and LSIL on Pap smear reports : Management by repeat Pap smear, HPV-DNA testing, or colposcopy?
36. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolau smear reports of ASCUS and LgSIL
37. The problem with low-grade Pap smears
38. Screening for cervical cancer
39. HPV testing in primary screening of older women
40. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial
41. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age
42. Role of routine human papillomavirus subtyping in cervical cancer screening
43. A systematic review of the role of human papillomavirus testing within a cervical screening programme
44. Use of hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus
45. Cervical cancer, Pap smear and HPV testing: An update of the role of organized Pap smear screening and HPV testing
46. HPV testing in the evaluation of the minimally abnormal Papanicolau smear
47. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer
48. Human papillomavirus testing in women with mild cytologic atypia
49. Where is the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolau diagnoses